Relation of adiponectin to glucose tolerance status, adiposity, and cardiovascular risk factor load

Experimental Diabetes Research

Volumn 2012, Issue , 2012, Pages

  Wolfson, N ^a   Gavish, D ^a   Matas, Z ^b   Boaz, M ^a   Shargorodsky, M ^a  

^a TEL AVIV UNIVERSITY   (Israel)

^b WOLFSON MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; C REACTIVE PROTEIN; GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; ADIPOQ PROTEIN, HUMAN; BIOLOGICAL MARKER; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C PROTEIN, HUMAN; LIPID;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BODY MASS; CARDIOVASCULAR RISK; CLINICAL ASSESSMENT; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; DYSLIPIDEMIA; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE HOMEOSTASIS; GLUCOSE TOLERANCE; HUMAN; HYPERTENSION; IMPAIRED GLUCOSE TOLERANCE; MAJOR CLINICAL STUDY; MALE; MEAN ARTERIAL PRESSURE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PRIORITY JOURNAL; SMOKING; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; AGED; BLOOD; CARDIOVASCULAR DISEASE; CASE CONTROL STUDY; DOWN REGULATION; GLUCOSE INTOLERANCE; ISRAEL; MIDDLE AGED; PATHOPHYSIOLOGY; RISK ASSESSMENT; RISK FACTOR;

ADIPONECTIN; ADIPOSITY; AGED; BIOLOGICAL MARKERS; BLOOD GLUCOSE; C-REACTIVE PROTEIN; CARDIOVASCULAR DISEASES; CASE-CONTROL STUDIES; DIABETES MELLITUS, TYPE 2; DOWN-REGULATION; FEMALE; GLUCOSE INTOLERANCE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; INSULIN; ISRAEL; LIPIDS; MALE; MIDDLE AGED; RISK ASSESSMENT; RISK FACTORS;

EID: 84855604873     PISSN: 16875214     EISSN: 16875303     Source Type: Journal    
DOI: 10.1155/2012/250621     Document Type: Article

References (26)

1. Stefan N., Vozarova B., Funahashi T., Matsuzawa Y., Weyer C., Lindsay R. S., Youngren J. F., Havel P. J., Pratley R. E., Bogardus C., Antonio Tataranni P., Plasma adiponectin concentration is associated with skeletal muscle insulin receptor tyrosine phosphorylation, and low plasma concentration precedes a decrease in whole-body insulin sensitivity in humans Diabetes 2002 51 6 1884 1888 (Pubitemid 34564302)
2. Yokota T., Oritani K., Takahashi I., Ishikawa J., Matsuyama A., Ouchi N., Kihara S., Funahashi T., Tenner A. J., Tomiyama Y., Matsuzawa Y., Adiponectin, a new member of the family of soluble defense collagens, negatively regulates the growth of myelomonocytic progenitors and the functions of macrophages Blood 2000 96 5 1723 1732 (Pubitemid 30661055)
3. Ouchi N., Kihara S., Arita Y., Nishida M., Matsuyama A., Okamoto Y., Ishigami M., Kuriyama H., Kishida K., Nishizawa H., Hotta K., Muraguchi M., Ohmoto Y., Yamashita S., Funahashi T., Matsuzawa Y., Adipocyte-derived plasma protein, adiponectin, suppresses lipid accumulation and class A scavenger receptor expression in human monocyte-derived macrophages Circulation 2001 103 8 1057 1063 (Pubitemid 32200177)
4. Tan K. C. B., Xu A., Chow W. S., Lam M. C. W., Ai V. H. G., Tam S. C. F., Lam K. S. L., Hypoadiponectinemia is associated with impaired endothelium-dependent vasodilation Journal of Clinical Endocrinology and Metabolism 2004 89 2 765 769 (Pubitemid 38269891)
5. Shargorodsky M., Boaz M., Goldberg Y., Matas Z., Gavish D., Fux A., Wolfson N., Adiponectin and vascular properties in obese patients: is it a novel biomarker of early atherosclerosis International Journal of Obesity 2009 33 5 553 558
6. Strk S., Bots M. L., Angerer P., von Schacky C., Grobbee D. E., Angermann C. E., Seufert J., Low levels of adiponectin predict worsening of arterial morphology and function Atherosclerosis 2007 194 2 e147 e153
7. Koenig W., Khuseyinova N., Baumert J., Meisinger C., Lwel H., Serum concentrations of adiponectin and risk of type 2 diabetes mellitus and coronary heart disease in apparently healthy middle-aged men. Results from the 18-year follow-up of a large cohort from Southern Germany Journal of the American College of Cardiology 2006 48 7 1369 1377 (Pubitemid 44436825)
8. Iwashima Y., Katsuya T., Ishikawa K., Ouchi N., Ohishi M., Sugimoto K., Fu Y., Motone M., Yamamoto K., Matsuo A., Ohashi K., Kihara S., Funahashi T., Rakugi H., Matsuzawa Y., Ogihara T., Hypoadiponectinemia is an independent risk factor for hypertension Hypertension 2004 43 6 1318 1323 (Pubitemid 38691756)
9. Hotta K., Funahashi T., Arita Y., Takahashi M., Matsuda M., Okamoto Y., Iwahashi H., Kuriyama H., Ouchi N., Maeda K., Nishida M., Kihara S., Sakai N., Nakajima T., Hasegawa K., Muraguchi M., Ohmoto Y., Nakamura T., Yamashita S., Hanafusa T., Matsuzawa Y., Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients Arteriosclerosis, Thrombosis, and Vascular Biology 2000 20 6 1595 1599 (Pubitemid 30353893)
10. Genuth S., Alberti K. G., Bennett P., The expert committee on the diagnosis and classification of diabetes mellitus follow-up report on the diagnosis of diabetes mellitus Diabetes Care 2003 26 3160 3167
11. Li L. L., Kang X. L., Ran X. J., Wang Y., Wang C. H., Huang L., Ren J., Luo X., Mao X. M., Associations between 45T/G polymorphism of the adiponectin gene and plasma adiponectin levels with type 2 diabetes Clinical and Experimental Pharmacology and Physiology 2007 34 12 1287 1290 (Pubitemid 350013237)
12. Stumvoll M., Tschritter O., Fritsche A., Staiger H., Renn W., Weisser M., Machicao F., Hring H., Association of the T-G polymorphism in adiponectin (Exon 2) with obesity and insulin sensitivity: interaction with family history of type 2 diabetes Diabetes 2002 51 1 37 41 (Pubitemid 34517977)
13. Pellmé F., Smith U., Funahashi T., Matsuzawa Y., Brekke H., Wiklund O., Taskinen M. R., Jansson P. A., Circulating adiponectin levels are reduced in nonobese but insulin-resistant first-degree relatives of type 2 diabetic patients Diabetes 2003 2 5 1182 1186 (Pubitemid 36523354)
14. Yamamoto Y., Hirose H., Saito I., Tomita M., Taniyama M., Matsubara K., Okazaki Y., Ishii T., Nishikai K., Saruta T., Correlation of the adipocyte-derived protein adiponectin with insulin resistance index and serum high-density lipoprotein-cholesterol, independent of body mass index, in the Japanese population Clinical Science 2002 103 2 137 142
15. Hung J., McQuillan B. M., Thompson P. L., Beilby J. P., Circulating adiponectin levels associate with inflammatory markers, insulin resistance and metabolic syndrome independent of obesity International Journal of Obesity 2008 32 5 772 779 (Pubitemid 351670618)
16. Krentz A. J., Mhlen D. V., Barrett-Connor E., Adipocytokines, sex hormones, and cardiovascular risk factors in postmenopausal women: factor analysis of the Rancho Bernardo study Hormone and Metabolic Research 2009 41 10 773 777
17. Kim S. G., Kim H. Y., Seo J. A., Lee K. W., Oh J. H., Kim N. H., Choi K. M., Baik S. H., Choi D. S., Relationship between serum adiponectin concentration, pulse wave velocity and nonalcoholic fatty liver disease European Journal of Endocrinology 2005 152 2 225 231 (Pubitemid 40309569)
18. Vozarova B., Stefan N., Lindsay R. S., Saremi A., Pratley R. E., Bogardus C., Antonio Tataranni P., High alanine aminotransferase is associated with decreased hepatic insulin sensitivity and predicts the development of type 2 diabetes Diabetes 2002 51 6 1889 1895 (Pubitemid 34564303)
19. Choi K. M., Lee J., Lee K. W., Seo J. A., Oh J. H., Kim S. G., Kim N. H., Choi D. S., Baik S. H., Serum adiponectin concentrations predict the developments of type 2 diabetes and the metabolic syndrome in elderly Koreans Clinical Endocrinology 2004 61 1 75 80 (Pubitemid 38951648)
20. Lenchik L., Register T. C., Hsu F. C., Lohman K., Nicklas B. J., Freedman B. I., Langefeld C. D., Carr J. J., Bowden D. W., Adiponectin as a novel determinant of bone mineral density and visceral fat Bone 2003 33 4 646 651 (Pubitemid 37222391)
21. Arita Y., Kihara S., Ouchi N., Takahashi M., Maeda K., Miyagawa J. I., Hotta K., Shimomura I., Nakamura T., Miyaoka K., Kuriyama H., Nishida M., Yamashita S., Okubo K., Matsubara K., Muraguchi M., Ohmoto Y., Funahashi T., Matsuzawa Y., Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity Biochemical and Biophysical Research Communications 1999 257 1 79 83 (Pubitemid 29299050)
22. Matsubara M., Maruoka S., Katayose S., Inverse relationship between plasma adiponectin and leptin concentrations in normal-weight and obese women European Journal of Endocrinology 2002 147 2 173 180
23. Kumada M., Kihara S., Sumitsuji S., Coronary artery disease association of hypoadiponectinemia with coronary artery disease in men Arteriosclerosis, Thrombosis, and Vascular Biology 2003 23 85 89 (Pubitemid 36091630)
24. Pischon T., Girman C. J., Hotamisligil G. S., Rifai N., Hu F. B., Rimm E. B., Plasma adiponectin levels and risk of myocardial infarction in men Journal of the American Medical Association 2004 291 14 1730 1737 (Pubitemid 38489895)
25. Schulze M. B., Shai I., Rimm E. B., Li T., Rifai N., Hu F. B., Adiponectin and future coronary heart disease events among men with type 2 diabetes Diabetes 2005 54 2 534 539
26. Costacou T., Zgibor J. C., Evans R. W., Otvos J., Lopes-Virella M. F., Tracy R. P., Orchard T. J., The prospective association between adiponectin and coronary artery disease among individuals with type 1 diabetes. The Pittsburgh epidemiology of diabetes complications study Diabetologia 2005 48 1 41 48 (Pubitemid 40174655)